Project Grant R01HL175602
Award Date
9/6/24
Completion Date
6/30/29
Dollars Obligated
$1.3M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) totaling $549,555.45 provides funding for a 3-year research study on the respiratory health effects of electronic cigarette (e-cigarette) use among young adults. The primary objectives are to: 1) evaluate the relationship between e-cigarette use and exposure to chemical constituents of concern (metals...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $3,002,492 to the University of Virginia (UVA) to evaluate the impact of e-cigarette use on lung health in young adults. The key objectives are to: Use hyperpolarized xenon-129 MRI (HXEMRI) to detect early physiological changes in the lungs of young e-cigarette users compared to non-users, and corroborate these findings with cardiopulmonary...
This federal Project Grant award of $3,230,000 from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will fund research by the University of California, San Francisco (UCSF) to investigate the cardiovascular effects of dual use of cigarettes and e-cigarettes. The key goals of the 5-year project are to: (1) understand the cardiovascular health impacts of dual use of various nicotine...
This Project Grant award, totaling $187,500.00, was issued by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The award to North Carolina Central University (NCCU) aims to investigate the potential immunosuppressive effects of e-cigarette (e-cig) vaping on the lungs, and whether vaping exposure could render the lungs more susceptible to microbial infections. The project will utilize ex vivo human bronchial...
This federal Project Grant award of $1,951,307 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a large-scale, 5-year study on dual use of combustible and electronic cigarettes. The primary awardee, the Medical University of South Carolina, will collaborate with sub-awardees the University of Vermont and the University of New Mexico to conduct a naturalistic cohort study involving daily diaries, monthly surveys, and biological...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), is focused on investigating the potential transgenerational epigenetic effects of e-cigarette use and nicotine exposure on abdominal aortic aneurysm (AAA) risk. The $355,000 award, granted to the Palo Alto Veterans Institute for Research (PAVIR), will support a multi-year research effort to examine how e-cigarette vapor and...
The National Institutes of Health (NIH), through the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), awarded a $669,321 project grant to the Regents of the University of California at Riverside (UC Riverside). The grant supports a 1-year study to characterize new and emerging ingredients, acids, toxicants, and indicators of non-tobacco nicotine in electronic cigarette (e-cigarette) products. The research will involve: Analyzing 600 commercial...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $687,995 to Yale University to investigate effective interventions and cessation effects on cancer-related biomarkers for adults who use e-cigarettes. The 5-year study will randomly assign 326 participants to receive either varenicline or a placebo, along with brief cessation advice and self-management resources, to test the efficacy of varenicline for quitting...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $619,477 to West Virginia University Research Corporation to conduct research on the impacts of electronic cigarette (e-cigarette) exposure on vascular dysfunction and cognitive decline. The key objectives are to: 1) establish a dose-response relationship between e-cigarette exposure and the development of vascular dysfunction, as...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $1,854,091.28 to Texas A&M University System Health Science Center to conduct research on the mechanistic impact of paternal electronic nicotine delivery system (ENDS) exposure on thrombogenesis. The study aims to determine the effects of paternal ENDS exposure, including e-waterpipes and e-cigarettes, on normal hemostasis,...